These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23883555)

  • 1. Updated therapeutic strategy for adult low-grade glioma stratified by resection and tumor subtype.
    Nitta M; Muragaki Y; Maruyama T; Iseki H; Ikuta S; Konishi Y; Saito T; Tamura M; Chernov M; Watanabe A; Okamoto S; Maebayashi K; Mitsuhashi N; Okada Y
    Neurol Med Chir (Tokyo); 2013; 53(7):447-54. PubMed ID: 23883555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.
    Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y
    Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assessment of prognostic factors in surgical treatment of low-grade gliomas: a prospective study.
    Majchrzak K; Kaspera W; Bobek-Billewicz B; Hebda A; Stasik-Pres G; Majchrzak H; Ładziński P
    Clin Neurol Neurosurg; 2012 Oct; 114(8):1135-44. PubMed ID: 22425370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
    Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
    J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.
    Smith JS; Chang EF; Lamborn KR; Chang SM; Prados MD; Cha S; Tihan T; Vandenberg S; McDermott MW; Berger MS
    J Clin Oncol; 2008 Mar; 26(8):1338-45. PubMed ID: 18323558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of DNA ploidy with intraoperative flow cytometry may predict long-term survival of patients with supratentorial low-grade gliomas: Analysis of 102 cases.
    Suzuki A; Maruyama T; Nitta M; Komori T; Ikuta S; Chernov M; Tamura M; Kawamata T; Muragaki Y
    Clin Neurol Neurosurg; 2018 May; 168():46-53. PubMed ID: 29522936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult low-grade glioma: 19-year experience at a single institution.
    Youland RS; Brown PD; Giannini C; Parney IF; Uhm JH; Laack NN
    Am J Clin Oncol; 2013 Dec; 36(6):612-9. PubMed ID: 22892428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current knowledge and treatment strategies for grade II gliomas.
    Narita Y
    Neurol Med Chir (Tokyo); 2013; 53(7):429-37. PubMed ID: 23883553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery.
    Rostomily RC; Spence AM; Duong D; McCormick K; Bland M; Berger MS
    Neurosurgery; 1994 Sep; 35(3):378-88; discussion 388. PubMed ID: 7800129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.
    McGirt MJ; Chaichana KL; Attenello FJ; Weingart JD; Than K; Burger PC; Olivi A; Brem H; Quinoñes-Hinojosa A
    Neurosurgery; 2008 Oct; 63(4):700-7; author reply 707-8. PubMed ID: 18981880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study.
    Jeremic B; Milicic B; Grujicic D; Samardzic M; Antunovic V; Dagovic A; Aleksandrovic J
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):509-14. PubMed ID: 15145170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma.
    Hervey-Jumper SL; Zhang Y; Phillips JJ; Morshed RA; Young JS; McCoy L; Lafontaine M; Luks T; Ammanuel S; Kakaizada S; Egladyous A; Gogos A; Villanueva-Meyer J; Shai A; Warrier G; Rice T; Crane J; Wrensch M; Wiencke JK; Daras M; Oberheim Bush NA; Taylor JW; Butowski N; Clarke J; Chang S; Chang E; Aghi M; Theodosopoulos P; McDermott M; Jakola AS; Kavouridis VK; Nawabi N; Solheim O; Smith T; Berger MS; Molinaro AM
    J Clin Oncol; 2023 Apr; 41(11):2029-2042. PubMed ID: 36599113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upfront Therapy of Aggressive/High-Risk Low-Grade Glioma: Single-Institution Outcome Analysis of Temozolomide-Based Radio-Chemotherapy and Adjuvant Chemotherapy.
    Anand S; Chatterjee A; Gupta T; Panda P; Moiyadi A; Epari S; Patil V; Krishnatry R; Goda JS; Jalali R
    World Neurosurg; 2021 Oct; 154():e176-e184. PubMed ID: 34245877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of surgically treated low-grade gliomas: a retrospective analysis of a single institute.
    Turkoglu E; Gurer B; Sanli AM; Dolgun H; Gurses L; Oral NA; Donmez T; Sekerci Z
    Clin Neurol Neurosurg; 2013 Dec; 115(12):2508-13. PubMed ID: 24225484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the Prognostic Role of Age, Extent of Resection, and Tumor Grade between Astrocytoma IDHmt and Oligodendroglioma: A Single-Center Cohort Study.
    van der Vaart T; Wijnenga MMJ; van Garderen K; Dubbink HJ; French PJ; Smits M; Dirven CMF; Kros JM; Vincent AJPE; van den Bent MJ
    Clin Cancer Res; 2024 Sep; 30(17):3837-3844. PubMed ID: 38990096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.
    Gorlia T; Delattre JY; Brandes AA; Kros JM; Taphoorn MJ; Kouwenhoven MC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ
    Eur J Cancer; 2013 Nov; 49(16):3477-85. PubMed ID: 23896377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supratentorial astrocytomas and oligodendrogliomas treated in the MRI era.
    Sakata K; Hareyama M; Komae T; Shirato H; Watanabe O; Watarai J; Takai K; Yamada S; Tsuchida E; Sakai K
    Jpn J Clin Oncol; 2001 Jun; 31(6):240-5. PubMed ID: 11463800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database Analysis.
    Jairam V; Kann BH; Park HS; Miccio JA; Beckta JM; Yu JB; Prabhu RS; Gao SJ; Mehta MP; Curran WJ; Bindra RS; Contessa JN; Patel KR
    Anticancer Res; 2019 Jun; 39(6):2911-2918. PubMed ID: 31177129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas.
    Hong JB; Roh TH; Kang SG; Kim SH; Moon JH; Kim EH; Ahn SS; Choi HJ; Cho J; Suh CO; Chang JH
    Cancer Res Treat; 2020 Oct; 52(4):1041-1049. PubMed ID: 32324987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.
    Koo T; Lim DH; Seol HJ; Dho YS; Kim IH; Chang JH; Lee J; Jung TY; Gwak HS; Cho KH; Hong CK; Lee IJ; Kim E; Kim JH; Hong YK; Jang HS; Kim CY; Kim IA; Kim SH; Kim YI; Kim EY; Kim WC; Hong S
    J Neurooncol; 2018 Nov; 140(2):445-455. PubMed ID: 30097825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.